Generics Form Essential Bridge to COVID-19 Vaccine
Dan Leonard, the newly named CEO of the Association for Accessible Medicines, believes that generic and biosimilar medicines are an [...]
Addressing Health Inequities Through Traditional Value Frameworks
Join Jason Shafrin, Vice President of Health Economics, and Meena Venkatachalam, Senior Director of Health Economics at PRECISIONheor as they [...]
Clinical Trial Design from a Program Perspective
Join Cytel’s co-founder, Nitin Patel, as he discusses the value in designing clinical trials from a program-level perspective. This webinar [...]
2021 Sternfels Prize Contest Now Open
The $35,000 cash is awarded to the most novel, clinically relevant, and testable ideas in research that aim to reduce [...]
[Webinar] Getting Started With Real World Evidence
Real world evidence (RWE) is becoming increasingly important for stakeholders as they make decisions across product lifecycles. IQVIA has made [...]
Are Virtual Medical Conferences The New Normal?
Thanks to COVID-19, the gradual trend toward virtual platforms has rushed forward at breakneck speed, resulting in a diverse array [...]
Prof. Thomas Rice on Shifting Behavior to Flatten the Curve
In an interview with ISPOR, distinguished professor of the Department of Health Policy and Management at UCLA, Thomas Rice, talks [...]
Jens Gruger Outlines Vision For ISPOR
Jens Gruger assumed the role of President of ISPOR writing: "I have assumed my role as President of ISPOR at [...]
Improving National Clinical Datasets for Health Equity Research
In spite of focused clinical, research, and policy efforts, great disparities in healthcare and outcomes persist. According to researchers, the [...]
No Need for Trump to Eliminate Rebates
In July, the Trump administration announced its intention to eliminate rebates for Medicare Part D drugs to lower prescription drug [...]
[Webinar] 5 Years of ICER – Insights and Impact on Payers
Payers are increasingly reliant on ICER reports for their formulary decision making process. Join this webinar on Tuesday, September 15, [...]
Regulators Need to Plan Now For Allocating COVID-19 Vaccine
Not enough attention is being paid to how exactly a COVID-19 vaccine will be rolled out. What will happen after [...]
Non-submissions to NICE on the Rise Much to the Chagrin of the NHS
The National Institute for Health and Care Excellence’s (NICE) treatment appraisal is a voluntary process. If companies opt not to [...]
Emmy Award-winning Journalist, Epidemiologist, Author and Physician Seema Yasmin Slated to Give ISMPP West 2020 Keynote Address on October 1
Dr. Yasmin received her medical degree from the University of Cambridge and her journalism degree from the University of Toronto. [...]
With Dr. Robert Dubois at the Helm, the National Pharmaceutical Council (NPC) Solidifies Commitment to High-Quality Patient-Centered Research and Evidence-based Dialogue
Dr. Robert Dubois, the newly appointed interim president and CEO of NPC, outlined his vision for the organization during his [...]
New CMS Proposal Aims to Expand Coverage for Breakthrough Devices
On Monday, the Centers for Medicare and Medicaid Services announced a proposed rule that would provide four year coverage for [...]
How Can Bayesian Borrowing Enhance Use of Real World Data (RWD)?
As the use of real-world data becomes more common in trial design and regulatory submission, Bayesian borrowing techniques are of [...]
FDA’s Use of Real-World Data (RWD) in the Fight Against COVID-19 Leaves Much to Be Desired
Although the FDA has gone to great lengths to integrate RWD into the fight against COVID-19, the agency still has [...]
The Medical Affairs Role Receives a Makeover in Europe
The new MedTech regulatory environment in Europe is providing exciting new opportunities for the evolution of the Medical Affairs function, [...]
Challenge and opportunity abound Through Remote Patient Monitoring
Identifying a cohort and then recruiting and monitoring clinical trial patients is an expensive and time-consuming exercise. Remote Patient Monitoring [...]
How Can Payers Prepare for the New Normal When the Targets Keep Moving?
It is frequently said that the pandemic is ushering in a new normal, a normal that changes as our understanding [...]
Podcast with Dr. John Selby: ‘Right Now, It Is No Longer Optional to Suck at Patient Centricity’
Join Dr. Selby the [now-retired] executive director of Patient-Centered Outcomes Research Institute. (PCORI) for a discussion of the importance of [...]
Health Disparities Worsened by Structural Racism Inherent in Medicaid Program
Authors of a Health Affairs blog posit that Medicaid’s history and politics are evidence that the program is steeped in [...]
What is the Current State of Real-World Evidence (RWE) Across all Biopharmas?
The need for high-quality Real-World Evidence (RWE) is growing as drugmakers recognizing the enormous potential and value in RWE. Studies [...]
Blue Cross and Blue Shield North Carolina Saves Millions Through Value-based Care
Blue Cross and Blue Shield North Carolina (Blue Cross NC) implemented a value-based care program that achieved substantial cost savings [...]